Cargando…
Natriuretic peptides in cardiovascular diseases
The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Versita
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275881/ https://www.ncbi.nlm.nih.gov/pubmed/17965966 http://dx.doi.org/10.2478/s11658-007-0046-6 |
_version_ | 1783377899695374336 |
---|---|
author | Piechota, Mariusz Banach, Maciej Jacoń, Anna Rysz, Jacek |
author_facet | Piechota, Mariusz Banach, Maciej Jacoń, Anna Rysz, Jacek |
author_sort | Piechota, Mariusz |
collection | PubMed |
description | The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and BNP inhibit endothelin-1 (ET-1) production. ET-1 stimulates natriuretic peptide synthesis. All natriuretic peptides are synthesized from polypeptide precursors. Changes in natriuretic peptides and endothelin release were observed in many cardiovascular diseases: e.g. chronic heart failure, left ventricular dysfunction and coronary artery disease. |
format | Online Article Text |
id | pubmed-6275881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | SP Versita |
record_format | MEDLINE/PubMed |
spelling | pubmed-62758812018-12-10 Natriuretic peptides in cardiovascular diseases Piechota, Mariusz Banach, Maciej Jacoń, Anna Rysz, Jacek Cell Mol Biol Lett Review Article The natriuretic peptide family comprises atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), and urodilatin. The activities of natriuretic peptides and endothelins are strictly associated with each other. ANP and BNP inhibit endothelin-1 (ET-1) production. ET-1 stimulates natriuretic peptide synthesis. All natriuretic peptides are synthesized from polypeptide precursors. Changes in natriuretic peptides and endothelin release were observed in many cardiovascular diseases: e.g. chronic heart failure, left ventricular dysfunction and coronary artery disease. SP Versita 2008-04-10 /pmc/articles/PMC6275881/ /pubmed/17965966 http://dx.doi.org/10.2478/s11658-007-0046-6 Text en © Versita 2007 |
spellingShingle | Review Article Piechota, Mariusz Banach, Maciej Jacoń, Anna Rysz, Jacek Natriuretic peptides in cardiovascular diseases |
title | Natriuretic peptides in cardiovascular diseases |
title_full | Natriuretic peptides in cardiovascular diseases |
title_fullStr | Natriuretic peptides in cardiovascular diseases |
title_full_unstemmed | Natriuretic peptides in cardiovascular diseases |
title_short | Natriuretic peptides in cardiovascular diseases |
title_sort | natriuretic peptides in cardiovascular diseases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275881/ https://www.ncbi.nlm.nih.gov/pubmed/17965966 http://dx.doi.org/10.2478/s11658-007-0046-6 |
work_keys_str_mv | AT piechotamariusz natriureticpeptidesincardiovasculardiseases AT banachmaciej natriureticpeptidesincardiovasculardiseases AT jaconanna natriureticpeptidesincardiovasculardiseases AT ryszjacek natriureticpeptidesincardiovasculardiseases |